Alpha Tau Medical Ltd. (DRTS) shareholders
Close on Nov 17, 2026Market cap $1.06BP/E –Yield –
Ownership
Who owns Alpha Tau Medical's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. Joint filing with Oramed Ltd. (19.99%) | 14,110,121 | 19.99% | 13D (active) | Apr 24, 2025 |
| Uzi Sofer | 13,702,361 | 15.80% | 13G (passive) | Dec 31, 2022 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Uzi Sofer | Chief Executive Officer, Director | 4,680 | Mar 18, 2026 |
| Raphi Levy | Chief Financial Officer | 93,051 | Aug 25, 2026 |
| Maya Netser | Director | 4,680 | Mar 18, 2026 |
| Michael Avruch | Director | 1,571,961 | Mar 18, 2026 |
| David Mark Milch | Director | 118,110 | Mar 18, 2026 |
| Alan Adler | Director | 54,367 | Mar 18, 2026 |
| Nadav Kidron | Director | 2,986 | Mar 18, 2026 |
| S. Morry Blumenfeld | Director | 4,680 | Mar 18, 2026 |
| Ruth Alon | Director | 4,680 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Raphi Levy Chief Financial Officer | Aug 21, 2026 | Option exercise | +2,871 | $2.98 | $8.56K | 93,051 |
| Raphi Levy Chief Financial Officer | Aug 21, 2026 | Sale(10b5-1 plan) | −2,871 | $15.00 | $43.07K | 90,180 |
| Raphi Levy Chief Financial Officer | Aug 11, 2026 | Option exercise | +17,730 | $2.98 | $52.84K | 107,910 |
| Raphi Levy Chief Financial Officer | Aug 11, 2026 | Sale(10b5-1 plan) | −17,730 | $14.00 | $248.22K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 6, 2026 | Option exercise | +2,270 | $2.98 | $6.76K | 92,450 |
| Raphi Levy Chief Financial Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −2,270 | $14.00 | $31.78K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 2, 2026 | Option exercise | +17,873 | $2.98 | $53.26K | 108,053 |
| Raphi Levy Chief Financial Officer | Jul 2, 2026 | Sale(10b5-1 plan) | −17,873 | $13.00 | $232.35K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −2,127 | $13.02 | $27.69K | 90,180 |
| Raphi Levy Chief Financial Officer | Jul 1, 2026 | Option exercise | +2,127 | $2.98 | $6.34K | 92,307 |
| Raphi Levy Chief Financial Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −20,000 | $12.00 | $240.00K | 90,180 |
| Raphi Levy Chief Financial Officer | Jun 25, 2026 | Sale(10b5-1 plan) | −15,778 | $11.00 | $173.56K | 110,180 |
| Raphi Levy Chief Financial Officer | Jun 25, 2026 | Sale(10b5-1 plan) | −4,222 | $11.00 | $46.44K | 125,958 |
| Raphi Levy Chief Financial Officer | Jun 23, 2026 | Sale(10b5-1 plan) | −2,500 | $10.00 | $25.00K | 130,180 |
| Raphi Levy Chief Financial Officer | Jun 23, 2026 | Sale(10b5-1 plan) | −15,000 | $9.47 | $142.05K | 132,680 |
| Raphi Levy Chief Financial Officer | Jun 3, 2026 | Sale | −17,500 | $10.90 | $190.75K | 162,680 |
| Raphi Levy Chief Financial Officer | Jun 3, 2026 | Sale | −15,000 | $10.76 | $161.40K | 147,680 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alpha Tau Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 62,337 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Raphael (Raphi) Aryeh Levy Officer | Aug 21, 2026 | 5,000 | $71.80K | Aug 21, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jul 6, 2026 | 20,000 | $264.60K | Jul 6, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jul 2, 2026 | 20,000 | $251.60K | Jul 1, 2026 | Shares acquired upon exercise of employee stock options |
| Raphi Levy Officer | Jun 30, 2026 | 20,000 | $224.40K | Jun 30, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 26, 2026 | 20,000 | $201.00K | Jun 25, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 23, 2026 | 17,500 | $175.53K | Jun 23, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Jun 4, 2026 | 32,500 | $290.23K | Jun 3, 2026 | Shares issued upon vesting of RSUs |
| Raphi Levy Officer | Feb 26, 2026 | 10,000 | $73.95K | Feb 25, 2026 | Restricted Stock Units |
| Gat Amnon Officer | Feb 2, 2026 | 87,010 | $603.85K | Feb 2, 2026 | Employee Stock Options plan |
| Raphi Levy Officer | Jan 14, 2026 | 15,000 | $106.35K | Jan 13, 2026 | Restricted Stock Units |
| Raphi Levy Officer | Jan 12, 2026 | 25,000 | $160.25K | Jan 9, 2026 | RSU |
| Gat Amnon Officer | Jan 9, 2026 | 61,745 | $364.30K | Jan 8, 2026 | Employee Stock Options plan |
| Raphi Levy Officer | Jan 9, 2026 | 20,000 | $118.00K | Jan 8, 2026 | RSU |
| Gat Amnon Officer | Dec 11, 2025 | 60,092 | $254.19K | Dec 10, 2025 | Employee Stock Options plan |
| Gat Amnon Officer | Dec 1, 2025 | 16,000 | $63.52K | Dec 1, 2025 | Employee Stock Options plan |
See a number that looks wrong?